Mortality and Medical Comorbidity in the Severely Mentally Ill
- PMID: 31366432
- PMCID: PMC6683445
- DOI: 10.3238/arztebl.2019.0405
Mortality and Medical Comorbidity in the Severely Mentally Ill
Abstract
Background: Mentally ill patients die on average 10 years earlier than the general population, largely due to general medical disorders. This study is the first to explore in a large German sample the prevalence, mortality, and medical comorbidity in pa- tients with severe mental illness (SMI). The patients were affected by borderline personality disorder (BPD), psychotic disorders, bipolar disorder, or severe unipolar depression.
Methods: Our database consists of billing data from all adults with statutory health insurance in Germany. Twelve-month administrative SMI prevalence and medical comorbidity were estimated using cross-sectional data from 2016 (age ≥ 18; N = 59 561 310). Two-year mortality was established longitudinally in a randomly selected subset of the billing data (most recent mortality information available for 2012 to 2014; 2012: n = 15 590 107).
Results: Severe unipolar depression had the highest prevalence (2.01%), followed by psychotic disorders (1.25%), BPD (0.34%), and bipolar disorder (0.29%). While the prevalence of malignant neoplasms showed moderate deviations from reference values [severe unipolar depression: OR = 1.30 (95% CI = 1.29; 1.31), BPD: OR = 1.11 (1.09; 1.14), psychotic dis- orders: OR = 0.90 (0.89; 0.90), bipolar disorder: OR = 1.07 (1.06; 1.09)], other disease groups (infectious, endocrine/nutritional/ metabolic, circulatory, respiratory) were substantially elevated in all categories of SMI. Mortality rates for psychotic disorders, BPD, bipolar disorder, and severe unipolar depression were increased (OR = 2.38 [95% CI=2.32; 2.44], 2.30 [2.08; 2.54], 1.52 [1.42; 1.62], and 1.40 [1.37; 1.44], respectively), with a loss of 2.6 to 12.3 years, depending on age, sex, and SMI.
Conclusion: Mortality is substantially elevated in all SMI patients. The results underline the need to remove barriers to adequate general medical care, both on the patient and the provider side, to reduce excess mortality.
Figures



Comment in
-
Risk of Rehospitalization can be Reduced.Dtsch Arztebl Int. 2019 Oct 11;116(41):689. doi: 10.3238/arztebl.2019.0689a. Dtsch Arztebl Int. 2019. PMID: 31709973 Free PMC article. No abstract available.
-
In Reply.Dtsch Arztebl Int. 2019 Oct 11;116(41):689-690. doi: 10.3238/arztebl.2019.0689b. Dtsch Arztebl Int. 2019. PMID: 31709974 Free PMC article. No abstract available.
Similar articles
-
[Disease burden of borderline personality disorder: cost of illness, somatic comorbidity and mortality].Nervenarzt. 2021 Jul;92(7):660-669. doi: 10.1007/s00115-021-01139-4. Epub 2021 Jun 7. Nervenarzt. 2021. PMID: 34097089 Review. German.
-
Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia.J Clin Psychiatry. 2007 Jun;68(6):899-907. doi: 10.4088/jcp.v68n0612. J Clin Psychiatry. 2007. PMID: 17592915
-
Factors associated with borderline personality disorder in major depressive patients and their relationship to bipolarity.Eur Psychiatry. 2013 Oct;28(8):463-8. doi: 10.1016/j.eurpsy.2012.11.007. Epub 2013 Feb 8. Eur Psychiatry. 2013. PMID: 23402737
-
Is comorbid borderline personality disorder in patients with major depressive episode and bipolarity a developmental subtype? Findings from the international BRIDGE study.J Affect Disord. 2013 Jan 10;144(1-2):72-8. doi: 10.1016/j.jad.2012.06.008. Epub 2012 Aug 2. J Affect Disord. 2013. PMID: 22858216
-
Psychosis in borderline personality disorder.Psychiatr Dev. 1984 Winter;2(4):295-308. Psychiatr Dev. 1984. PMID: 6396640 Review.
Cited by
-
The impact of COVID-19 pandemic on people with severe mental illness.Perspect Psychiatr Care. 2021 Apr;57(2):953-956. doi: 10.1111/ppc.12618. Epub 2020 Sep 19. Perspect Psychiatr Care. 2021. PMID: 32949183 Free PMC article. Review.
-
Characteristics of clinical-pharmacological recommendations in psychiatry in Germany.Int J Psychiatry Med. 2024 May;59(3):393-405. doi: 10.1177/00912174231177230. Epub 2023 May 16. Int J Psychiatry Med. 2024. PMID: 37194304 Free PMC article.
-
Impact of COVID-19 in the Mental Health in Elderly: Psychological and Biological Updates.Mol Neurobiol. 2021 May;58(5):1905-1916. doi: 10.1007/s12035-020-02249-x. Epub 2021 Jan 6. Mol Neurobiol. 2021. PMID: 33404981 Free PMC article. Review.
-
Pharmacological interventions for people with borderline personality disorder.Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD012956. doi: 10.1002/14651858.CD012956.pub2. Cochrane Database Syst Rev. 2022. PMID: 36375174 Free PMC article.
-
Embitterment and metacognition in obsessive-compulsive disorder.BMC Psychiatry. 2023 Mar 8;23(1):146. doi: 10.1186/s12888-023-04642-x. BMC Psychiatry. 2023. PMID: 36890494 Free PMC article.
References
-
- Wahlbeck K, Westman J, Nordentoft M, Gissler M, Laursen TM. Outcomes of nordic mental health systems: life expectancy of patients with mental disorders. Br J Psychiatry. 2011;199:453–458. - PubMed
-
- Hjorthøj C, Østergaard MLD, Benros ME, et al. Association between alcohol and substance use disorders and all-cause and cause-specific mortality in schizophrenia, bipolar disorder, and unipolar depression: A nationwide, prospective, register-based study. The Lancet Psychiatry. 2015;2:801–808. - PubMed